[go: up one dir, main page]

MX2019011510A - Metodos y composiciones para mejorar la salud. - Google Patents

Metodos y composiciones para mejorar la salud.

Info

Publication number
MX2019011510A
MX2019011510A MX2019011510A MX2019011510A MX2019011510A MX 2019011510 A MX2019011510 A MX 2019011510A MX 2019011510 A MX2019011510 A MX 2019011510A MX 2019011510 A MX2019011510 A MX 2019011510A MX 2019011510 A MX2019011510 A MX 2019011510A
Authority
MX
Mexico
Prior art keywords
compositions
methods
enhancing health
enhancing
health
Prior art date
Application number
MX2019011510A
Other languages
English (en)
Inventor
Kleidon William
Original Assignee
Ojai Energetics Pbc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ojai Energetics Pbc filed Critical Ojai Energetics Pbc
Publication of MX2019011510A publication Critical patent/MX2019011510A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105—Persulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Las composiciones, métodos y equipos descritos en la presente pueden formularse como un suplemento nutricional o un suplemento dietético. La composición descrita en la presente puede proporcionar nutrientes o compuestos que de otro modo no se consumirían en cantidades suficientes en una dieta normal, y pueden contribuir al bienestar físico y al bienestar emocional de un sujeto.
MX2019011510A 2017-03-30 2018-03-23 Metodos y composiciones para mejorar la salud. MX2019011510A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762479091P 2017-03-30 2017-03-30
US201762506475P 2017-05-15 2017-05-15
US201862632965P 2018-02-20 2018-02-20
PCT/US2018/024061 WO2018183115A1 (en) 2017-03-30 2018-03-23 Methods and compositions for enhancing health

Publications (1)

Publication Number Publication Date
MX2019011510A true MX2019011510A (es) 2020-01-09

Family

ID=63676925

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019011510A MX2019011510A (es) 2017-03-30 2018-03-23 Metodos y composiciones para mejorar la salud.
MX2022004262A MX2022004262A (es) 2017-03-30 2019-09-26 Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022004262A MX2022004262A (es) 2017-03-30 2019-09-26 Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.

Country Status (11)

Country Link
US (1) US20200101041A1 (es)
EP (1) EP3600271A4 (es)
JP (3) JP2020512358A (es)
CN (1) CN110709069A (es)
AU (2) AU2018243694A1 (es)
BR (1) BR112019020554A2 (es)
CA (1) CA3057994A1 (es)
GB (1) GB2577810A (es)
IL (1) IL269642B1 (es)
MX (2) MX2019011510A (es)
WO (1) WO2018183115A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
AU2018417229B2 (en) * 2018-04-04 2024-12-19 Vinsan Therapeutics Inc. Topical cannabinoid formulations and instillates, kits, and methods for treating integumentary wounds, and uses thereof
EP3793542A4 (en) * 2018-05-14 2022-03-30 Buzzelet Development And Technologies Ltd TERPENE-ENRICHED CANNABINOID COMPOSITIONS AND THEIR USES IN THE TREATMENT OF INFECTIOUS DISEASES
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
WO2020084450A1 (en) * 2018-10-23 2020-04-30 Radient Technologies Innovations Inc. Method of automating cannabis decarboxylation and extraction by recursive decarboxylation, sampling, and extraction steps
WO2020084425A1 (en) * 2018-10-24 2020-04-30 Radient Technologies Innovations Inc. Side effect and symptom relief
AU2019397508A1 (en) 2018-12-14 2021-06-24 Natural Extraction Systems, LLC Compositions and methods related to anionic cannabinoid molecules
US10959961B2 (en) * 2018-12-14 2021-03-30 Natural Extraction Systems, LLC Methods of administering anionic cannabinoid molecules dissolved in water
US10609944B1 (en) 2018-12-14 2020-04-07 Natural Extraction Systems, LLC Compositions comprising 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-3-hydroxy-5-pentylphenolate and 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
US12433904B2 (en) 2019-04-17 2025-10-07 Compass Pathfinder Limited Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
US11622956B1 (en) 2019-06-26 2023-04-11 RCR BioPharma Compound and method for treating diseases and disorders
WO2021016710A1 (en) * 2019-07-30 2021-02-04 Tassili Life Sciences, Corp. Controlled release formulations of multiple active pharmaceutical agents, and psilocybe-derived agents in combination with cannabis-derived agents and methods for their use
US10780075B1 (en) * 2019-07-31 2020-09-22 Etain IP, LLC Water soluble cannabis composition
US10945953B1 (en) 2019-09-12 2021-03-16 Nulixir Inc. Controlled release core-shell particles and suspensions including the same
WO2022026960A1 (en) 2020-07-31 2022-02-03 Natural Extraction Systems, LLC Compositions and methods related to excipients and cannabinoid formulations
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol
CA3216717A1 (en) 2021-04-30 2022-11-03 Mind Medicine, Inc. Lsd salt crystal forms
US20220362319A1 (en) * 2021-05-12 2022-11-17 PPM Labs LLC Cannabinoid Concentration Process
US12527786B2 (en) 2021-08-19 2026-01-20 Mind Medicine, Inc. Immediate release formulations of d-lysergic acid diethylamide for therapeutic applications
US12060328B2 (en) 2022-03-04 2024-08-13 Reset Pharmaceuticals, Inc. Co-crystals or salts of psilocybin and methods of treatment therewith
CN120213091B (zh) * 2025-05-28 2025-08-15 浙江机电职业技术大学 一种高温共烧结的多层异形陶瓷高温传感器及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2400320B (en) 2001-05-04 2005-06-08 Gw Pharma Ltd Cannabinoid-rich extracts
US8980940B2 (en) * 2006-11-10 2015-03-17 Johnson Matthey Public Limited Company Stable cannabinoid compositions and methods for making and storing them
US8642645B2 (en) * 2011-05-20 2014-02-04 Brooks Kelly Research, LLC. Pharmaceutical composition comprising Cannabinoids
US10792318B2 (en) * 2013-03-14 2020-10-06 Sc Laboratories, Inc. Bioactive concentrates and uses thereof
JP2016537412A (ja) * 2013-10-31 2016-12-01 フル スペクトラム ラボラトリーズ，エルティーディー． テルペン及びカンナビノイドの製剤
NZ731248A (en) * 2014-10-21 2024-04-26 United Cannabis Corp Cannabis extracts and methods of preparing and using same
US9375417B2 (en) * 2014-12-04 2016-06-28 Mary's Medicinals LLC Transdermal cannabinoid formulations
EP3250200A4 (en) 2015-01-31 2018-09-19 Constance Therapeutics, Inc. Methods for preparation of cannabis oil extracts and compositions
MX2017010872A (es) * 2015-02-27 2018-05-07 Ebbu Llc Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales.
US9747740B2 (en) * 2015-03-02 2017-08-29 Ford Global Technologies, Llc Simultaneous button press secure keypad code entry
US20170042791A1 (en) * 2015-08-11 2017-02-16 KannaInnovations LLC Topical compositions comprising hydroxy acids and cannabinoids for skin care
CN109152748A (zh) * 2016-05-06 2019-01-04 哈维斯特·迪莱科特企业有限公司 口服大麻药物的制造方法、组合物和医学应用
AU2017307643B2 (en) * 2016-08-03 2019-07-25 Zelira Therapeutics Operations Pty Ltd Cannabis Composition
US20180344786A1 (en) * 2017-06-06 2018-12-06 NC3 Systems System and method enhanced cannabiniod effect delivery
BR112020004772A2 (pt) * 2017-09-28 2020-09-24 Canopy Growth Corporation composições comestíveis de canabinoides

Also Published As

Publication number Publication date
GB201914076D0 (en) 2019-11-13
JP2020512358A (ja) 2020-04-23
BR112019020554A2 (pt) 2020-04-28
IL269642B1 (en) 2025-12-01
EP3600271A4 (en) 2020-12-16
JP7624035B2 (ja) 2025-01-29
US20200101041A1 (en) 2020-04-02
CA3057994A1 (en) 2018-10-04
JP2023139315A (ja) 2023-10-03
AU2018243694A1 (en) 2019-10-17
CN110709069A (zh) 2020-01-17
JP2025061440A (ja) 2025-04-10
EP3600271A1 (en) 2020-02-05
MX2022004262A (es) 2022-05-06
GB2577810A (en) 2020-04-08
IL269642A (en) 2019-11-28
WO2018183115A1 (en) 2018-10-04
AU2024203369A1 (en) 2024-06-06

Similar Documents

Publication Publication Date Title
MX2019011510A (es) Metodos y composiciones para mejorar la salud.
MX2017007550A (es) Composiciones microencapsuladas de cannabinoides.
BR112018003745A2 (pt) composições que compreendem um composto de urolitina
ECSP15034601A (es) Composiciones nutricionales que contienen treonato de magnesio, y sus usos
MX2017008813A (es) Polvo de coleopteros.
BR112018003780A2 (pt) composições que compreendem um composto de urolitina
MX2016012559A (es) Composiciones de protector solar.
ECSP17043318A (es) Composición que contiene quitina y proteínas digeribles
MX2013005406A (es) Composicion nutricional adaptada a la edad con grasas animales y grasas vegetales.
MX2015015630A (es) Acido graso del aceite de bogol.
BR112015026207A2 (pt) uso de uma preparação na fabricação de uma composição nutricional, composição nutricional, uso de uma composição nutricional, uso de uma composição, composição, e método para tratamento ou fornecimento de gerenciamento nutricional de pacientes com hiperfenilalaninemia e/ou pacientes com fenilcetonúria
MX2021014352A (es) Composiciones de fibra soluble de superoxido dismutasa.
MX384995B (es) Composición que contiene aceite vegetal, caramelo y compuestos fenólicos.
AR100028A1 (es) Composiciones nutricionales que contienen ácido estearidónico
BR112015020568A2 (pt) composição para melhorar o desenvolvimento cognitivo, cerebral e/ou do snc do recém-nascido e método para o uso da mesma
PH12019550209A1 (en) A nutritional composition for use to enhance attention and/or reduce impulsivity
PH12017500203B1 (en) Nutritional composition for use in promoting gut and/or liver maturation and/or repair
PH12015502693A1 (en) A composition, process and a kit for sugar processing
BR112022007676A2 (pt) Composições e métodos para aumentar glutationa para uso na saúde cerebral
GB2528406A (en) Prebiotic composition and method of its use
PH12021551924A1 (en) A nutritional composition for use to enhance executive function
EA201992271A1 (ru) Способы и композиции для улучшения здоровья
PH22017001036Y1 (en) Food supplement for the nervous system
IN2013CH04898A (es)
IN2013CH04980A (es)